COPD market to expand with AstraZeneca’s focus on biologics and strong portfolio growth
AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender ...
BMJ12d
Systemic availability and pharmacokinetics of nebulised budesonide in preschool children
Approximately 6% of the nominal dose of budesonide (26% of dose to subject) reaches the systemic circulation of young children after inhalation from a Pari LC Jet Plus nebuliser Deposition of drug in ...
Medscape2d
New ACG Guideline on EoE Reflects Over a Decade of Advances in Diagnosis and Management
The guidelines support use of PPIs, dietary therapy, and biologics for EoE, and stress the importance of addressing both the ...
JP Morgan 2025: AstraZeneca promises a ‘catalyst-rich’ year ahead
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.Cho0xxI9.js ...
thorax.bmj7d
Inhaled corticosteroids and major cardiovascular events in people with chronic obstructive pulmonary disease
We explored treatment regimens (mono and combination therapies), ICS drug class-subtyping ... and an ‘MBBC-group’ (mometasone furoate, beclomethasone, budesonide or ciclesonide). The outcome was a ...
pharmaphorum1d
FDA changes its mind and approves Takeda’s Eohilia
The US regulator has cleared Eohilia (formerly TAK-721), an oral suspension formulation of the well-established steroid drug budesonide, for people 11 years and older with EoE after turning down ...
pharmaphorum1d
CSL, Travere close on EU approval of IgAN drug sparsentan
The drug – already granted accelerated approval ... at a discount to Calliditas’ corticosteroid-based Tarpeyo (budesonide) therapy, which became the first FDA-approved therapy for IgAN in ...
verywellhealth8d
Knowing Inhaler Colors and What They Mean
This group also includes SMART drugs like Symbicort (budesonide and formoterol fumarate dihydrate ... Rogliani P, Calzetta L, Coppola A, et al. Optimizing drug delivery in COPD: the role of inhaler ...
emjreviews.com15d
ACG Updates Guidelines For Eosinophilic Oesophagitis Management
The use of swallowed topical steroids, such as fluticasone propionate or budesonide, is strongly recommended as the ... For patients who do not respond to PPI therapy, the biologic drug dupilumab is ...
EMS122h
Understanding dexamethasone: Reviewing the risks, benefits and evidence
Let’s look specifically at dexamethasone, a common corticosteroid in emergency medicine, and use current research to describe what the drug does ... like budesonide, have different indications ...
verywellhealth26d
Managing Asthma Flare-Ups
In January 2023, the Food and Drug Administration (FDA) approved Airsupra (albuterol and budesonide). Airsupra is a combination of a SABA and an inhaled corticosteroid (ICS) for the treatment of acute ...
BMJ22d
Intranasal antihistamines and corticosteroids in the treatment of allergic rhinitis: a systematic review and meta-analysis protocol
The following intranasal drugs will be considered: azelastine, azelastine–fluticasone, beclomethasone, budesonide, ciclesonide ... In addition, considering Food and Drug Administration recommendations ...